| |
Commitment to Access
|
Commitment to Access
PO Box 29038
Phoenix, AZ 85038-9038
Phone
:
(866) 265-6491
Fax:
|
|
Eligibility
|
| > |
The patient must have no prescription coverage for the medication and have an income at or below 350% of the Federal Poverty Level. The patient must also be a US resident. GlaxoSmithKline requests that an Advocate be the contact person for the patient throughout the entire process. The advocate can be any healthcare worker involved in the patient' care (i.e., doctor, nurse, social worker, or someone in the healthcare office or facility). In a reversal of an earlier announcement, GlaxoSmithKline reported on May 3rd that it's Patient Assistance Programs will be available to Medicare enrollees that do not sign up for a Part D drug program. However, patients who may be eligible for the Part D Low Income Subsidy will be required to apply for this benefit. GSK will continue to supply these patients with their medicine until a decision has been made as to whether they will receive the subsidy. If you have further questions feel free to contact customer service at 1-888-825-5249. |
| Who Can Apply
|
| > |
The patient advocate can call for an application or start the application process on line. The application will be faxed out. The completed application can be faxed or mailed back. Notification of acceptance or denial is sent to whomever started the application process.
|
|
Required
|
| > |
The doctor must fill out a section, sign the application and attach a prescription. The patient must fill out a section, sign the application and attach proof of income.
|
|
Supply
|
| > |
A 30-day supply is sent to the doctor's office. |
|
Ship To
|
| > |
Physician's office. |
|
Note
|
| > |
The doctor/doctor's office must contact the company to arrange refills. Every year a new application is needed. |
| |
Includes Support for This Drug
NOTE: Linked drugs are available for Prescribers to Apply Online now.
Click drug logo or drug name to start online application.
|
| Bexxar Injection |
| Hycamtin Injection |
| Leukeran Tablets |
| Myleran Tablets |
| Tabloid Tablet |
| Tykerb |
| Zofran Tablets-orally disintergrating |
| |
| |
|
|